HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,676 | -13.4% | 32,695 | -2.5% | 0.00% | – |
Q2 2023 | $38,889 | +98.9% | 33,525 | +158.9% | 0.00% | – |
Q1 2023 | $19,555 | -34.5% | 12,950 | +8.4% | 0.00% | – |
Q4 2022 | $29,875 | -49.4% | 11,950 | -14.3% | 0.00% | – |
Q3 2022 | $59,000 | +40.5% | 13,950 | -7.3% | 0.00% | – |
Q2 2022 | $42,000 | -55.3% | 15,050 | -8.8% | 0.00% | – |
Q1 2022 | $94,000 | -36.5% | 16,500 | +1.5% | 0.00% | – |
Q4 2021 | $148,000 | -7.5% | 16,250 | +8.7% | 0.00% | – |
Q3 2021 | $160,000 | -49.7% | 14,943 | -27.0% | 0.00% | – |
Q2 2021 | $318,000 | +29.3% | 20,465 | +34.6% | 0.00% | – |
Q1 2021 | $246,000 | -4.7% | 15,200 | +24.5% | 0.00% | – |
Q4 2020 | $258,000 | -20.1% | 12,210 | -43.9% | 0.00% | -100.0% |
Q3 2020 | $323,000 | +17.9% | 21,783 | +16.7% | 0.00% | – |
Q2 2020 | $274,000 | +14.6% | 18,658 | +203.7% | 0.00% | -100.0% |
Q2 2018 | $239,000 | – | 6,144 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |